Gerresheimer AG - Company Profile
Powered by 
All the sales intelligence you need on Gerresheimer AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Gerresheimer AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Gerresheimer AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Gerresheimer AG (Gerresheimer) is a provider of drug delivery devices and medicine packaging products. It specializes in pharmaceutical containment solutions, drug delivery systems, and medical devices, offering a range of products such as medication pumps, syringes, pens, auto-injectors, inhalers, vials, cartridges, and ampoules. Gerresheimer's products are utilized by customers in the pharma, biotech, diagnostics, and medical technology sectors, providing solutions for safe drug delivery and administration. The company's offerings find application in respiratory disease treatment and diabetes management. Gerresheimer serves a diverse customer base, including national and regional pharmacy chains, supermarkets, and wholesalers. The company operates production sites across Europe, America, and Asia. Gerresheimer is headquartered in Dusseldorf, Nordrhein-Westfalen, Germany.
Headquarters
Germany
Address
Peter-Mueller-Strasse 3, Duesseldorf, Nordrhein-Westfalen, 40468
Website
www.gerresheimer.com
Telephone
49 211 618100
No of Employees
13,528
Industry
Paper and Packaging
Ticker Symbol & Exchange
GXI (ETR)
Revenue (2024)
$2.5B
16.6%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-489.3%
(2024 vs 2023)
Market Cap*
$1.1B
Net Profit Margin (2024)
XYZ
-434.1%
(2024 vs 2023)
* As of and is in US$
Gerresheimer AG premium industry data and analytics
Products and Services
| Products |
|---|
| Ampoules |
| Vials |
| Cartridges |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Corporate Changes/Expansions | In October, the company launched a new production facility at its Wertheim site in Germany. |
| 2025 | Contracts/Agreements | In September, the company expanded its partnership with Portal Instruments to commercialize the Prime NEXUS reusable autoinjector platform. |
| 2025 | Plans/Strategy | In August, the company announced its plans to separate the Moulded Glass business. |
Competitor Comparison
| Key Parameters | Gerresheimer AG | Amcor Plc | Sonoco Products Co | Krones AG | AptarGroup Inc |
|---|---|---|---|---|---|
| Headquarters | Germany | Switzerland | United States of America | Germany | United States of America |
| City | Duesseldorf | Zuerich | Hartsville | Neutraubling | Crystal Lake |
| State/Province | Nordrhein-Westfalen | - | South Carolina | Bayern | Illinois |
| No. of Employees | 13,528 | 77,000 | 22,000 | 21,299 | 14,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Bernd Metzner | Chief Financial Officer | Senior Management | 2019 | 56 |
| Dietmar Siemssen | Chief Executive Officer - Plastics and Devices and Advanced Technologies Division | Senior Management | 2019 | 63 |
| Axel Herberg | Chairman | Non Executive Board | 2014 | 68 |
| Markus Romer | Deputy Chairman | Non Executive Board | 2024 | 60 |
| Stefan Seuferling | Global Executive Vice President - Medical Systems | Senior Management | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer